https://www.investors.com/news/technology/ccxi-stock-rockets-as-amgen-plans-chemocentryx-takeover/
0
0
8/4/22 at 4:20pm
Organization
Investor's Business Daily
Author
Investor's Business Daily
The company will pay $52 per share to buy ChemoCentryx, a rare disease-focused firm.
Create an account
or login to join the discussion